SAN FRANCISCO: Smart ring maker Oura confidentially filed a Form S-1 with the U.S. Securities and Exchange Commission on May 21, 2026, setting up one of the year’s most-watched consumer tech IPOs. The company, last valued at $11 billion after a $900 million Series E in October 2025, said the offering will proceed after SEC review and subject to market conditions, according to CNBC’s report on the filing.
CEO Tom Hale told CNBC the company is on track to generate close to $2 billion in revenue in 2026, roughly double its 2025 run. Paid members are expected to top 5 million this quarter, a fourfold increase in two years. Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co. and Jefferies are running the deal, per Bloomberg’s coverage. Oura did not provide a price target or share-count range in its confidential submission, which is standard for emerging growth companies using the JOBS Act path to market.
How a $349 Ring Became an $11 Billion Subscription Business
Oura built its valuation on a model that consumer hardware companies have been trying to crack for a decade: a one-time device purchase that funnels customers into a recurring software subscription. The Oura Ring 4 sells for $349 and up. After the first month, members pay $5.99 monthly for the app’s full feature set, which covers sleep scoring, heart rate variability, readiness, and an AI-powered advisor the company built in-house.
The economics work because retention has held. Hale has said publicly that more than 80% of Oura members renew after the first year, a number that compares favorably with most consumer subscription products. The company also moved its headquarters from Oulu, Finland to San Francisco under Hale, who took the CEO seat in 2022, and has been spending against AI development and international expansion as the public market window approaches. Oura has raised more than $1.5 billion in total private capital across its life as a company, with the October 2025 Series E led by existing investors and joined by sovereign and crossover funds positioning ahead of the IPO.
The $11 billion private mark, set in October 2025, implies a revenue multiple of roughly 10x on 2025 sales and closer to 5.5x on the 2026 guide. That puts Oura in software-multiple territory despite earning the majority of its revenue from a physical device, which is precisely the bet public investors will be asked to validate. The comparison set on the public market is thin. Garmin trades at roughly 5x sales, Fitbit was acquired by Google at under 2x, and Apple’s wearables segment sits inside a much larger conglomerate. There is no clean public comparable for what Oura is selling, which is both the bull case and the risk.
What does Oura’s IPO mean for the wearables market?
Oura’s filing is a direct test of whether public markets will pay software multiples for hardware-anchored health products. A successful pricing would re-rate the entire smart ring category and force comparison shopping against Apple Watch, Garmin, and Whoop, which raised $575 million at a $10.1 billion valuation earlier this year, according to Athletech News.
The competitive frame matters. Apple controls more than 28% of the wearables market by unit volume and roughly 60% of smartwatch revenue, with Series 10 now shipping non-invasive glucose tracking. Garmin reported 42% year-over-year growth in its fitness wearables segment in Q1 2026. Smart rings still account for less than 1% of the total wearables market by unit volume, but the segment is growing at roughly 21% annually as Samsung and other entrants validate the form factor.
Oura’s pitch is that the ring is the only wearable people wear to sleep, which makes the data set defensible. The company also ships its own AI model rather than licensing one, which Hale has framed as a moat against larger competitors that might bolt health features onto existing devices. In March 2026, Oura announced a partnership to integrate ring data into clinical care pathways for chronic disease management, a move that positions the company closer to reimbursable medical-device territory and further from a pure consumer-gadget framing.
What to Watch Before the Pricing
The confidential filing means the financial details, gross margin, customer acquisition cost, subscription churn, and international revenue mix, stay private until the SEC clears the registration. That review typically takes 60 to 90 days, putting a potential roadshow in late summer or early fall. The Ring 5 launch, expected before the IPO prices, will also factor into the demand picture, as will guidance the company eventually publishes around medical-grade certifications and international Medicare-equivalent reimbursement programs.
The bigger signal is the IPO calendar around Oura. OpenAI filed confidentially the same week, per TechCrunch’s coverage, joining a queue that already includes SpaceX, Cerebras, Lime, and Fervo Energy. For founders watching the window, Oura’s pricing will be the cleanest read on whether public investors are paying for growth-plus-subscription stories at private-market multiples or demanding a discount. The answer sets the bar for every wearable, connected-device, and consumer-health startup behind it, and shapes how early-stage founders evaluating hardware-software hybrids should price their next round.
